Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
Maria Khan Junaidi, Deputy Program Director Vascular Neurology at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in European Stroke Journal, adding:
“Pleased to share our latest publication in the European Stroke Journal.
Clinical characteristics and outcomes of intracerebral haemorrhage in young vs. older adults: Insights from the INTERACT3 trial.
In this secondary analysis of 7,031 patients across 10 countries, we found that although younger adults (լess than or equal to 50 years) with ICH often had larger haematomas and a distinct vascular risk profile, they experienced significantly better 6-month outcomes and appeared to derive greater benefit from bundled acute ICH care.
These findings reinforce the importance of early, protocol-driven management while highlighting the need for targeted prevention strategies in younger patients with ICH.
Grateful to all collaborators and the INTERACT3 investigators for making this work possible.”
Title: Clinical characteristics and outcomes of intracerebral haemorrhage in young vs older adults: insights from the INTERACT3 trial
Authors: Maria Khan, Menglu Ouyang, Mohammad Wasay, Lu Ma, Xin Hu, Xiaoying Chen, Laurent Billot, Qiang Li, Paula Muñoz Venturelli, Asita de Silva, Nguyen Huy Thang, Kolawole W Wahab, Jeyaraj D Pandian, Octavio M Pontes-Neto, Carlos Abanto, Antonio Arauz, Chao You, Lili Song, Craig S Anderson
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 11:15Bridging Neurology and Thrombosis: Key Priorities from a New Expert Consensus Report – International Journal of Stroke
-
Aug 13, 2026, 11:05Khaled Musallam: The Evolving Landscape of β-Thalassemia: Clinical Trial Advances Since 2021
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure